{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:05:32Z","timestamp":1784210732908,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2023-YBSF-294"],"award-info":[{"award-number":["2023-YBSF-294"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402186"],"award-info":[{"award-number":["81402186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["21JS015"],"award-info":[{"award-number":["21JS015"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29166","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:52:18Z","timestamp":1712173938000},"page":"e29166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Revealing the active ingredients and mechanism of P. sibiricumm in non-small-cell lung cancer based on UPLC-Q-TOF-MS\/MS, network pharmacology, and molecular docking"],"prefix":"10.1016","volume":"10","author":[{"given":"Kaili","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e29166_bib1","first-page":"335","article-title":"Lung cancer: epidemiology and screening","volume":"102","author":"Oliver","year":"2022","journal-title":"Surg. Clin."},{"issue":"Supplement","key":"10.1016\/j.heliyon.2024.e29166_bib2","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.4103\/ijc.IJC_52_21","article-title":"Evolving trends in lung cancer: epidemiology, diagnosis, and management","volume":"59","author":"Deshpand","year":"2022","journal-title":"Indian J. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29166_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw.: J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.heliyon.2024.e29166_bib4","doi-asserted-by":"crossref","unstructured":"Su X-E, Hong W-P, He H-F, et al. Recent advances in postoperative pulmonary rehabilitation of patients with non\u2011small cell lung cancer (Review)[J]. International Journal of Oncology, 2022, 61(6): 156.","DOI":"10.3892\/ijo.2022.5446"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29166_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100612","article-title":"Clinical experience and management of adverse events in patients with advanced ALK-positive non-small-cell lung cancer receiving alectinib","volume":"7","author":"Dziadziuszko","year":"2022","journal-title":"ESMO open"},{"key":"10.1016\/j.heliyon.2024.e29166_bib6","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2147\/CMAR.S374648","article-title":"Research progress on radiotherapy combined with immunotherapy for associated pneumonitis during treatment of non-small cell lung cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancer Manag. Res."},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2024.e29166_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/resp.13915","article-title":"Pulmonary toxicity of systemic lung cancer therapy","volume":"25","author":"Long","year":"2020","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29166_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/03007995.2022.2085964","article-title":"Pulmonary toxicity in driver gene positive non-small cell lung cancer therapy","volume":"38","author":"Zhao","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.heliyon.2024.e29166_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer--From theory to practice","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29166_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1142\/S0192415X20500780","article-title":"Positive role of Chinese herbal medicine in cancer immune regulation","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29166_bib11","first-page":"729","article-title":"The prognostic impact of traditional Chinese medicine monomers on tumor-associated macrophages in non-small cell lung cancer","volume":"17","author":"Wan","year":"2019","journal-title":"Chin. J. Nat. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29166_bib12","first-page":"3571","article-title":"Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials","volume":"28","author":"Yang","year":"2020","journal-title":"Support. Care Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"32","key":"10.1016\/j.heliyon.2024.e29166_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020683","article-title":"Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer: a systematic review and meta-analysis","volume":"99","author":"Sui","year":"2020","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib14","first-page":"1132","article-title":"[Polygonati Rhizoma: a crop with potential of being consumed as food and medicine]","volume":"47","author":"Shi","year":"2022","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.heliyon.2024.e29166_bib15","article-title":"An evaluation of traits, nutritional, and medicinal component quality of polygonatum cyrtonema Hua and P. Sibiricum red","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.heliyon.2024.e29166_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijbiomac.2022.06.078","article-title":"Study on pharmacokinetics and tissue distribution of Polygonatum sibiricum polysaccharide in rats by fluorescence labeling","volume":"215","author":"Bi","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29166_bib17","first-page":"1886","article-title":"[Study on effect of Polygonatum sibiricum on Yin deficiency model rats induced by long-term overload swimming]","volume":"39","author":"Wu","year":"2014","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.heliyon.2024.e29166_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114164","article-title":"Polygonatum sibiricum polysaccharide prevents depression-like behaviors by reducing oxidative stress, inflammation, and cellular and synaptic damage","volume":"275","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29166_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113060","article-title":"Protective effect of Polygonatum sibiricum against cadmium-induced testicular injury in mice through inhibiting oxidative stress and mitochondria-mediated apoptosis","volume":"261","author":"Han","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29166_bib20","article-title":"Synergistic effect of polydatin and polygonatum sibiricum polysaccharides in combating atherosclerosis via suppressing TLR4-mediated NF-\u03baB activation in ApoE-deficient mice","volume":"2022","author":"Ye","year":"2022","journal-title":"Evid. base Compl. Alternative Med.: eCAM"},{"key":"10.1016\/j.heliyon.2024.e29166_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.carbpol.2014.10.034","article-title":"A polysaccharide from Polygonatum sibiricum attenuates amyloid-\u03b2-induced neurotoxicity in PC12 cells","volume":"117","author":"Zhang","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.heliyon.2024.e29166_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154404","article-title":"The beneficial effects of Polygonatum sibiricum Red. superfine powder on metabolic hypertensive rats via gut-derived LPS\/TLR4 pathway inhibition","volume":"106","author":"Su","year":"2022","journal-title":"Phytomedicine: International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29166_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jep.2017.12.006","article-title":"The genus Polygonatum: a review of ethnopharmacology, phytochemistry and pharmacology","volume":"214","author":"Zhao","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e29166_bib24","first-page":"4163","article-title":"[Research progress on processing history evolution, chemical components and pharmacological effects of Polygonati Rhizoma]","volume":"45","author":"Hong-Min","year":"2020","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.heliyon.2024.e29166_bib25","article-title":"Polygonatum polysaccharide regulates macrophage polarization and improves LPS-induced acute lung injury through TLR4-MAPK\/NF-\u03baB pathway","volume":"2022","author":"Zhou","year":"2022","journal-title":"Can. Respir. J. J. Can. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2024.e29166_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116027","article-title":"Integrated miRNA and mRNA omics reveal dioscin suppresses migration and invasion via MEK\/ERK and JNK signaling pathways in human endometrial carcinoma in vivo and in vitro","volume":"303","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41598-021-81485-0","article-title":"Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS\/MS and network pharmacology","volume":"11","author":"Lu","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/molecules28010295","article-title":"Screening and identification of anti-inflammatory compounds from erdong gao via multiple-target-cell extraction coupled with HPLC-Q-TOF-MS\/MS and their structure-activity relationship","volume":"28","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e29166_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional Chinese medicine: review and assessment","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29166_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201700048","article-title":"Network-based approaches in pharmacology","volume":"36","author":"Boezio","year":"2017","journal-title":"Molecular Informatics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib31","first-page":"1","article-title":"TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches","volume":"19","author":"Wang","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e29166_bib32","series-title":"Quality Analysis of Polygonati Rhizoma and Polygonati Rhizoma [ D ]","author":"Nan","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e29166_bib33","article-title":"Study on the effective components of P.polyphylla var.chinensis and screening of key genes for the synthesis of steroidal saponins","author":"Guan","year":"2023","journal-title":"D ], Chinese Academy of Chinese Medical Sciences"},{"key":"10.1016\/j.heliyon.2024.e29166_bib34","series-title":"Study on Chemical Constituents and Antidepressant Effects of Different Parts of D.Kingianum [ D ]","author":"Wang","year":"2018"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29166_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300458","article-title":"Discrimination of polygonati rhizoma species: an investigation utilizing high-performance liquid chromatography fingerprints and chemometrics","volume":"20","author":"Zhou","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib36","first-page":"365","article-title":"Chemical constituents of fresh polygonati Rhizoma","volume":"23","author":"Gao","year":"2015","journal-title":"Pharmaceutics and clinical research"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib37","first-page":"110","article-title":"UPLC-Q-TOF-MS-based chemical composition analysis of Polygonatum cyrtonema before and after processing","volume":"27","author":"Ren","year":"2021","journal-title":"Chinese Journal of Experimental Prescriptions"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e29166_bib38","first-page":"4948","article-title":"UPLC-Q-TOF-MS\/MS was used to analyze the changes of chemical components during the processing of Polygonati Rhizoma","volume":"53","author":"Liang","year":"2022","journal-title":"Chinese herbal medicine"},{"issue":"S1","key":"10.1016\/j.heliyon.2024.e29166_bib39","first-page":"271","article-title":"Rapid analysis and identification of chemical constituents of wild Polygonatum kingianum in Aba, Sichuan Province based on UPLC-Q-TOF-MS technology","volume":"48","author":"Ji","year":"2019","journal-title":"Application Chemical Industry"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29166_bib40","first-page":"43","article-title":"UPLC-Q\/TOF-MS-based component analysis of P. sibiricumm, P.cyrtonema and P.yunnanensis [ J ]","volume":"50","author":"Yang","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e29166_bib41","article-title":"Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"46","key":"10.1016\/j.heliyon.2024.e29166_bib42","doi-asserted-by":"crossref","first-page":"29755","DOI":"10.1021\/acsomega.0c03582","article-title":"Identification of antitumor active constituents in polygonatum sibiricum flower by UPLC-Q-TOF-MSE and network pharmacology","volume":"5","author":"Huang","year":"2020","journal-title":"ACS Omega"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e29166_bib43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/14786419.2014.927468","article-title":"Urgineaglyceride A: a new monoacylglycerol from the Egyptian Drimia maritima bulbs","volume":"28","author":"Mohamed","year":"2014","journal-title":"Nat. Prod. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.phymed.2013.10.004","article-title":"Effects of the root of Platycodon grandiflorum on airway mucin hypersecretion in vivo and platycodin D(3) and deapi-platycodin on production and secretion of airway mucin in vitro","volume":"21","author":"Ryu","year":"2014","journal-title":"Phytomedicine: International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29166_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108557","article-title":"Cytotoxic steroidal saponins from the rhizome of Anemarrhena asphodeloides","volume":"155","author":"Zhao","year":"2020","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29166_bib46","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1080\/03639045.2021.2001489","article-title":"Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activities","volume":"47","author":"Zaman","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29166_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202200823","article-title":"Extraction and identification of steroidal saponins from Polygonatum cyrtonema Hua using natural deep eutectic solvent-synergistic quartz sand-assisted extraction method","volume":"46","author":"Liu","year":"2023","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.heliyon.2024.e29166_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113452","article-title":"Steroidal saponin components and their cancer cell cytotoxicity from Paris rugosa","volume":"204","author":"Yu","year":"2022","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001492","article-title":"Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer","volume":"10","author":"Batra","year":"2023","journal-title":"BMJ open respiratory research"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtho.2015.12.103","article-title":"Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs","volume":"11","author":"Lin","year":"2016","journal-title":"J. Thorac. Oncol.: Official Publication of the International Association for the Study of Lung Cancer"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29166_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","article-title":"Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC","volume":"16","author":"Le","year":"2021","journal-title":"J. Thorac. Oncol.: Official Publication of the International Association for the Study of Lung Cancer"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29166_bib52","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s11864-022-01022-7","article-title":"New strategies and novel combinations in EGFR TKI-resistant non-small cell lung cancer","volume":"23","author":"Girard","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29166_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1470-2045(20)30641-0","article-title":"First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial","volume":"22","author":"Paz-Ares","year":"2021","journal-title":"Lancet Oncol."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e29166_bib54","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.19.03136","article-title":"Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer","volume":"38","author":"Gadgeel","year":"2020","journal-title":"J. Clin. Oncol.: Official Journal of the American Society of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29166_bib55","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jtho.2016.06.025","article-title":"EGFR-GRB2 protein colocalization is a prognostic factor unrelated to overall EGFR expression or EGFR mutation in lung adenocarcinoma","volume":"11","author":"Toki","year":"2016","journal-title":"J. Thorac. Oncol.: Official Publication of the International Association for the Study of Lung Cancer"},{"key":"10.1016\/j.heliyon.2024.e29166_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105007","article-title":"Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e29166_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2017.10.030","article-title":"\u03b1-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation","volume":"494","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10020-020-00193-z","article-title":"Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC","volume":"26","author":"Sun","year":"2020","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29166_bib59","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1080\/07391102.2020.1844801","article-title":"p38\u03b1 MAP kinase inhibitors to overcome EGFR tertiary C797S point mutation associated with osimertinib in non-small cell lung cancer (NSCLC): emergence of fourth-generation EGFR inhibitor","volume":"40","author":"Ahmad","year":"2022","journal-title":"J. Biomol. Struct. Dynam."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e29166_bib60","first-page":"2426","article-title":"The expression and significance of Rap1b in non-small cell lung cancer","volume":"23","author":"Ma","year":"2015","journal-title":"Modern Oncology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29166_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243891","article-title":"Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC","volume":"15","author":"Yu","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29166_bib62","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1210\/en.2013-2032","article-title":"Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, \u03b2-cell functions, and \u03b2-cell proliferation in male mice","volume":"155","author":"Shirakawa","year":"2014","journal-title":"Endocrinology"},{"issue":"28","key":"10.1016\/j.heliyon.2024.e29166_bib63","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41388-022-02376-w","article-title":"IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression","volume":"41","author":"Alfaro-Arnedo","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29166_bib64","first-page":"2991","article-title":"Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer","volume":"34","author":"Vilmar","year":"2014","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29166_bib65","first-page":"6694","article-title":"Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis","volume":"7","author":"Zhao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41571-023-00733-6","article-title":"Rare molecular subtypes of lung cancer","volume":"20","author":"Harada","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e29166_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lungcan.2020.04.020","article-title":"Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations","volume":"144","author":"Scheffler","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.heliyon.2024.e29166_bib68","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.biopha.2018.06.084","article-title":"MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway","volume":"106","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e29166_bib69","first-page":"1582","article-title":"High expression of Rab-like 3 (Rabl3) is associated with poor survival of patients with non-small cell lung cancer via repression of MAPK8\/9\/10-mediated autophagy","volume":"22","author":"Zhang","year":"2016","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.: International Medical Journal of Experimental and Clinical Research"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12935-021-01811-4","article-title":"CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29166_bib71","first-page":"837","article-title":"CircTADA2A up-regulates MAPK8 by targeting MiR-214-3p and recruiting EIF4A3 to promote the invasion and migration of non-small cell lung cancer cells","volume":"38","author":"Zhang","year":"2023","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29166_bib73","doi-asserted-by":"crossref","first-page":"11051","DOI":"10.1007\/s13277-014-2409-8","article-title":"SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer","volume":"35","author":"Jian","year":"2014","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29166_bib74","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1007\/s13277-015-3247-z","article-title":"MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29166_bib75","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1159\/000430244","article-title":"Placental growth factor promotes metastases of non-small cell lung cancer through MMP9","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell. Physiol. Biochem.: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"issue":"5670","key":"10.1016\/j.heliyon.2024.e29166_bib76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29166_bib77","article-title":"Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib78","first-page":"1966","article-title":"Raf1 is a prognostic factor for progression in patients with non-small cell lung cancer after radiotherapy","volume":"39","author":"Tian","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2024.e29166_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215783","article-title":"Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway","volume":"543","author":"Chen","year":"2022","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib80","first-page":"365","article-title":"The drug resistance mechanism and countermeasures of non-small cell lung cancer after osimertinib treatment","volume":"33","author":"Wang","year":"2020","journal-title":"Basic Clin. Oncol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29166_bib81","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/molecules24112165","article-title":"A ferulic acid derivative FXS-3 inhibits proliferation and metastasis of human lung cancer A549 cells via positive JNK signaling pathway and negative ERK\/p38, AKT\/mTOR and MEK\/ERK signaling pathways","volume":"24","author":"Yue","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29166_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gendis.2019.11.003","article-title":"The hippo tumor suppressor pathway (YAP\/TAZ\/TEAD\/MST\/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes & Diseases"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e29166_bib83","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.3390\/ijms20225701","article-title":"Current approaches in NSCLC targeting K-RAS and EGFR","volume":"20","author":"Aran","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29166_bib84","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.21037\/tlcr-20-141","article-title":"PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy","volume":"9","author":"Fang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e29166_bib85","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.2147\/OTT.S220462","article-title":"FGFR1 induces acquired resistance against gefitinib by activating AKT\/mTOR pathway in NSCLC","volume":"12","author":"Zhang","year":"2019","journal-title":"OncoTargets Ther."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2026.e44520","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000}},{"DOI":"10.1016\/j.heliyon.2026.e44520","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024051971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024051971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:17:09Z","timestamp":1784207829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024051971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024051971"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29166","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revealing the active ingredients and mechanism of P. sibiricumm in non-small-cell lung cancer based on UPLC-Q-TOF-MS\/MS, network pharmacology, and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29166"}}